dehydroepiandrosterone sulfate has been researched along with tamoxifen in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Purohit, A; Reed, MJ | 1 |
| Carlström, K; Pousette, A; Rannevik, G; Sköldefors, H; Theve, NO; Wilking, N | 1 |
| Gurpide, E; Markiewicz, L | 1 |
| Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
| Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY | 1 |
| Santen, RJ; Santner, SJ | 1 |
| Davis, W; Phillips, DH; Venitt, S | 1 |
| Kagaya, A; Kurata, K; Morinobu, S; Takebayashi, M; Yamawaki, S | 1 |
| Barker, JL; Chang, YH; Li, Bs; Ma, W; Rubinow, DR; Zhang, L; Zhao, W | 1 |
| Calhoun, K; Cheek, J; Fletcher, W; Pommier, R; Toth-Fejel, S | 1 |
| Nakajima, A; Sekihara, H; Takahashi, H | 1 |
| Hardin, C; Jackson, T; Lefleur, B; Pommier, R; Toth-Fejel, S | 1 |
| Botti, G; Chiodini, P; D'Aiuto, G; De Feo, G; De Maio, E; de Matteis, A; Di Maio, M; Di Rella, F; Esposito, G; Gallo, C; Gravina, A; Labonia, V; Landi, G; Morabito, A; Nuzzo, F; Pacilio, C; Perrone, F; Piccirillo, MC; Rossi, E | 1 |
| Coombes, RC; Januszewski, A; Palmieri, C; Stanway, S | 1 |
| Bauer, T; Hadji, P; Hasenburg, A; Kauka, A; Kieback, DG; Tams, J | 1 |
| Atherton, PJ; Barton, DL; Birrell, SN; Dockter, T; Griffin, P; Lafky, JM; Loprinzi, CL; Mattar, B; Shuster, LT; Sood, R; Terstriep, SA; Thielen, J | 1 |
1 review(s) available for dehydroepiandrosterone sulfate and tamoxifen
| Article | Year |
|---|---|
Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase II as Topic; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Steryl-Sulfatase; Sulfonic Acids; Tamoxifen | 2011 |
4 trial(s) available for dehydroepiandrosterone sulfate and tamoxifen
| Article | Year |
|---|---|
Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Ovary; Prednisolone; Prolactin; Receptors, Estrogen; Tamoxifen; Thyroxine | 1984 |
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.
Topics: Aged; Antineoplastic Agents; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Dehydroepiandrosterone Sulfate; Diphosphonates; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Imidazoles; Letrozole; Luteinizing Hormone; Middle Aged; Nitriles; Postmenopause; Progesterone; Receptors, Estrogen; Tamoxifen; Testosterone; Triazoles; Zoledronic Acid | 2009 |
Effects of exemestane and tamoxifen on hormone levels within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German substudy.
Topics: Aged; Androstadienes; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Germany; Hormones; Humans; Middle Aged; Parathyroid Hormone; Postmenopause; Receptors, Estrogen; Sex Hormone-Binding Globulin; Tamoxifen; Testosterone | 2012 |
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Topics: Administration, Intravaginal; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Genital Neoplasms, Female; Gonadal Steroid Hormones; Humans; Middle Aged; Osteogenesis; Postmenopause; Tamoxifen; Testosterone; Vagina | 2018 |
12 other study(ies) available for dehydroepiandrosterone sulfate and tamoxifen
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
Topics: Breast Neoplasms; Cell Division; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Humans; Kinetics; Receptors, Estrogen; Receptors, Progesterone; Sulfatases; Tamoxifen; Tumor Cells, Cultured | 1992 |
Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Topics: Aminoglutethimide; Breast Neoplasms; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Estrogens; Estrone; Female; Humans; Pregnadienes; Sex Hormone-Binding Globulin; Tamoxifen | 1986 |
C19 adrenal steroids enhance prostaglandin F2 alpha output by human endometrium in vitro.
Topics: Androstanes; Androstenediol; Culture Techniques; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Dinoprost; Endometrium; Estrogen Antagonists; Female; Humans; Prostaglandins F; Tamoxifen | 1988 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; Binding, Competitive; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Kinetics; Mammary Neoplasms, Experimental; Polyunsaturated Alkamides; Pregnenolone; Rats; Rats, Sprague-Dawley; Sulfatases; Tamoxifen | 1993 |
The metabolic activation of tamoxifen and alpha-hydroxytamoxifen to DNA-binding species in rat hepatocytes proceeds via sulphation.
Topics: Animals; Biotransformation; Cells, Cultured; Dehydroepiandrosterone Sulfate; Female; Liver; Rats; Rats, Inbred F344; Sulfates; Tamoxifen | 1998 |
Effect of beta-estradiol on voltage-gated Ca(2+) channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Androstenedione; Animals; Azlocillin; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dizocilpine Maleate; Estradiol; Estrogen Antagonists; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Hippocampus; Imidazolidines; N-Methylaspartate; Neurons; Nifedipine; Rats; Rats, Wistar; Tamoxifen | 2001 |
Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways.
Topics: Androgen Antagonists; Animals; Apoptosis; Chromones; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fetal Proteins; Flutamide; Morpholines; Nerve Tissue Proteins; Neurons; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen; Telencephalon | 2002 |
The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression.
Topics: Adult; Age Factors; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Dehydroepiandrosterone Sulfate; Disease Progression; Drug Resistance; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Retrospective Studies; Risk Factors; Tamoxifen; Tumor Cells, Cultured | 2003 |
Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.
Topics: Adult; Apoptosis; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flow Cytometry; Flutamide; Humans; Lymphocytes; Male; Middle Aged; Staurosporine; Tamoxifen | 2004 |
Understanding the biologic mechanisms responsible for breast-cancer progression during tamoxifen or fulvestrant treatment.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Disease Progression; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Tamoxifen; Treatment Failure; Tumor Cells, Cultured | 2004 |